Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference5 articles.
1. Wenzel J, Badde L, Haas SS, Bonivento C, Van Rheenen TE, Antonucci LA, et al. Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illness. Neuropsychopharmacology. 2023. Online ahead of print.
2. Van Rheenen TE, Lewandowski KE, Tan EJ, Ospina LH, Ongur D, Neill E, et al. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum. Psychol Med. 2017;47:1848–64.
3. Lewandowski KE, McCarthy JM, Öngür D, Norris LA, Liu GZ, Juelich RJ, et al. Functional connectivity in distinct cognitive subtypes in psychosis. Schizophr Res. 2019;204:120–6.
4. Catalan A, Salazar de Pablo G, Aymerich C, Damiani S, Sordi V, Radua J, et al. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021;78:859–67.
5. Abramovitch A, Short T, Schweiger A. The C Factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology. Clin Psychol Rev. 2021;86:102007.